Dr Matshidiso Moeti, WHO Regional Director for Africa, recalled that during the UN High-Level Meeting on Tuberculosis in 2008, world leaders agreed to mobilize US$13 billion per year to finance TB prevention and treatment by 2022, as well as another US$2 billion per year for TB research, in response to growing concerns about drug-resistant TB.
However, funding for TB prevention, diagnosis, and treatment services continues to fall far short of estimated global needs and the global target set by the United Nations.
Global spending on tuberculosis services fell to US$5.3 billion in 2020, with research funding totaling US$901 million.
While national strategic plans and accompanying budgets for tuberculosis have grown in ambition, mobilization of funding has not kept pace. In Africa, governments contribute only 22% of the resources required to deliver adequate TB services, with 44% going unfunded, seriously impeding efforts to reduce the TB burden.
Moeti made this in her message to commemorate the World TB Day which is observed on 24 March each year to raise public awareness and understanding about one of the globe’s deadliest infectious diseases, as well as its devastating health, social and economic impacts.
This year’s theme, “Invest to end TB. Save lives”, emphasizes the urgent need to invest the resources necessary to ramp up the fight against TB, and realize the commitments to end TB made by global leaders
According to her, “South Africa and Zambia are the best examples of high TB burden countries that have steadily increased domestic funding specifically allocated for TB. In 2020, South Africa provided 81% of domestic funding to support TB activities. Zambia has increased its domestic funding seven-fold since 2015.
“Increased funding from domestic sources and international donors is urgently needed if we are to counteract a reversal of the significant gains made against TB in the past decades. At the current rate of progress, the UN Sustainable Development Goals (SDGs) target of ending the TB epidemic by 2030 will not be achievable.
“To reach the target, TB incidence would have had to record an annual decline of 4% to 5% in 2020, increasing to 10% per year by 2025, and then to an average 17% annually in the following decade. In fact, the world saw an increase in the number of global TB deaths for the first time in over a decade in 2021. Contributing factors included reduced access to TB diagnosis and treatment, in the face of the COVID-19 pandemic.
“With 36% of all TB deaths occurring in Africa, failure to invest in the TB response is set to take a formidable toll on African countries. Increased investment can be a game-changer, and alleviate the preventable suffering and death of millions of our people”, she said.
She, however, called on governments to mobilize additional domestic financial support for TB control, including contributions to the Global Fund, which last month launched its US$18-billion Seventh Replenishment campaign in a bid to counter the catastrophic impact of COVID-19 on the fight against TB.
Moeti also urged all stakeholders to advocate for increased investment, and to ensure that TB services are integrated into the primary health care response. We must all also work more closely with our communities, leveraging their expert local knowledge to tailor response efforts for maximum impact.
While appealing to donors, the private sector, civil society and academia to pay increased attention to urgently boosting investment in the fight against TB and in TB research, in order to accelerate technological breakthroughs and uptake of innovations towards ending TB by 2030.
